About This Report3This new 280-page report from VPGMarketResearch.com presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, the report:-  Examines market applications of Molecular Diagnostics,     Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; -  Reviews features and operating characteristics of major analyzers used    for STD testing; -  Profiles key suppliers and potential market entrants developing innovative   technologies and products; and -  Analyzes emerging opportunities, alternative market penetration strategies,    market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review ofthe most recent technical and business publications, manufacturer productand financial literature, as well as VPGMarketResearch.com’s proprietary data... Research Beam Model: Research Beam Product ID: 302979 0 USD New
2015-2019 Emerging Opportunities in the Japanese Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015-2019 Emerging Opportunities in the Japanese Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

 
  • Category : Diagnostic and Biotech
  • Published On : July  2015
  • Pages : 280
 
 

About This Report3

This new 280-page report from VPGMarketResearch.com presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used
   for STD testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies,
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch.com’s proprietary data files was conducted.
 
Contains 280 pages and 17 tables